Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;36:912-916

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitworth, J. A.
Right arrow Articles by Kelly, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitworth, J. A.
Right arrow Articles by Kelly, J. J.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Secondary prevention
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Clinical Studies
Right arrow Receptor pharmacology
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2000;36:912.)
© 2000 American Heart Association, Inc.


Colin Johnston - A Celebration

Cushing, Cortisol, and Cardiovascular Disease

Judith A. Whitworth; George J. Mangos; John J. Kelly

From John Curtin School of Medical Research, The Australian National University, Canberra, ACT (J.A.W.); and the Departments of Medicine and Renal Medicine, St George Hospital, University of New South Wales, Kogarah, NSW (G.J.M., J.J.K.).

Correspondence to Judith A. Whitworth, John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601.

Abstract—Cushing’s syndrome of glucocorticoid excess is named after the eminent Boston neurosurgeon Harvey W. Cushing (1869-1939). The recognition that glucocorticoid excess produces hypertension led to examination of the role of cortisol in essential hypertension, but it is only over the last decade that evidence has emerged to support the concept. Despite the widespread assumption that cortisol raises blood pressure as a consequence of renal sodium retention, there are few data consistent with the notion. Although it has a plethora of actions on brain, heart and blood vessels, kidney, and body fluid compartments, precisely how cortisol elevates blood pressure is unclear. Candidate mechanisms currently being examined include inhibition of the vasodilator nitric oxide system and increases in vasoconstrictor erythropoietin concentration.


Key Words: brain • glucocorticoids • hypertension, essential • cortisol • blood pressure




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
A. J Rickard and M. J Young
Corticosteroid receptors, macrophages and cardiovascular disease
J. Mol. Endocrinol., June 1, 2009; 42(6): 449 - 459.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. B. Lodish, N. Sinaii, N. Patronas, D. L. Batista, M. Keil, J. Samuel, J. Moran, S. Verma, J. Popovic, and C. A. Stratakis
Blood Pressure in Pediatric Patients with Cushing Syndrome
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2002 - 2008.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. G. Bechtold, G. Patel, G. Hochhaus, and D. A. Scheuer
Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1445 - R1454.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Sun, E. Sheveleva, B. Xu, H. Inoue, T. G. Bowden, and Q. M. Chen
Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-{beta}
Am J Physiol Cell Physiol, October 1, 2008; 295(4): C915 - C922.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Baum and O. W. Moe
Glucocorticoid-Mediated Hypertension: Does the Vascular Smooth Muscle Hold All the Answers?
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1251 - 1253.
[Full Text] [PDF]


Home page
J EndocrinolHome page
A L Markel, O E Redina, M A Gilinsky, G M Dymshits, E V Kalashnikova, Y. V Khvorostova, L A Fedoseeva, and G S Jacobson
Neuroendocrine profiling in inherited stress-induced arterial hypertension rat strain with stress-sensitive arterial hypertension
J. Endocrinol., December 1, 2007; 195(3): 439 - 450.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. R Walker
Glucocorticoids and Cardiovascular Disease
Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. A. Scheuer, A. G. Bechtold, and K. A. Vernon
Chronic Activation of Dorsal Hindbrain Corticosteroid Receptors Augments the Arterial Pressure Response to Acute Stress
Hypertension, January 1, 2007; 49(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Subramanian, M. A. DeRosa, C. Bernal-Mizrachi, N. Laffely, W. T. Cade, K. E. Yarasheski, P. E. Cryer, and C. F. Semenkovich
PPAR{alpha} activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1365 - E1371.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. J.M. Broadley, A. Korszun, E. Abdelaal, V. Moskvina, J. Deanfield, C. J.H. Jones, and M. P. Frenneaux
Metyrapone Improves Endothelial Dysfunction in Patients With Treated Depression
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 170 - 175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. G. Bechtold and D. A. Scheuer
Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1003 - R1011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. M. Firoved, G. F. Miller, M. Moayeri, R. Kakkar, Y. Shen, J. F. Wiggins, E. M. McNally, W.-J. Tang, and S. H. Leppla
Bacillus anthracis Edema Toxin Causes Extensive Tissue Lesions and Rapid Lethality in Mice
Am. J. Pathol., November 1, 2005; 167(5): 1309 - 1320.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Gold, I. Dziobek, K. Rogers, A. Bayoumy, P. F. McHugh, and A. Convit
Hypertension and Hypothalamo-Pituitary-Adrenal Axis Hyperactivity Affect Frontal Lobe Integrity
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3262 - 3267.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. Wei, T. M. MacDonald, and B. R. Walker
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Ann Intern Med, November 16, 2004; 141(10): 764 - 770.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A.-M. Samuelsson, I. Ohrn, J. Dahlgren, E. Eriksson, B. Angelin, B. Folkow, and A. Holmang
Prenatal Exposure to Interleukin-6 Results in Hypertension and Increased Hypothalamic-Pituitary-Adrenal Axis Activity in Adult Rats
Endocrinology, November 1, 2004; 145(11): 4897 - 4911.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. M. Freel and J. M.C. Connell
Mechanisms of Hypertension: The Expanding Role of Aldosterone
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1993 - 2001.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. A. Scheuer, A. G. Bechtold, S. S. Shank, and S. F. Akana
Glucocorticoids act in the dorsal hindbrain to increase arterial pressure
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H458 - H467.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. N. Kerstens, F. G. H. van der Kleij, A. H. Boonstra, W. J. Sluiter, J. Koerts, G. Navis, and R. P. F. Dullaart
Salt Loading Affects Cortisol Metabolism in Normotensive Subjects: Relationships with Salt Sensitivity
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4180 - 4185.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. L. Muiesan, M. Lupia, M. Salvetti, C. Grigoletto, N. Sonino, M. Boscaro, E. A. Rosei, F. Mantero, and F. Fallo
Left ventricular structural and functional characteristics in Cushing's syndrome
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2275 - 2279.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. P.F. Chin-Dusting, B. A. Ahlers, D. M. Kaye, J. J. Kelly, and J. A. Whitworth
L-Arginine Transport in Humans With Cortisol-Induced Hypertension
Hypertension, June 1, 2003; 41(6): 1336 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. S. Shank and D. A. Scheuer
Glucocorticoids reduce responses to AMPA receptor activation and blockade in nucleus tractus solitarius
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1751 - H1761.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. M.C. Connell, R. Fraser, S. MacKenzie, and E. Davies
Is Altered Adrenal Steroid Biosynthesis a Key Intermediate Phenotype in Hypertension?
Hypertension, May 1, 2003; 41(5): 993 - 999.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Terzolo, A. Pia, A. Ali, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Borretta, et al.
Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome?
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 998 - 1003.
[Abstract] [Full Text] [PDF]